Cencora, Inc. (COR)
257.71
-3.40
(-1.30%)
USD |
NYSE |
May 15, 16:00
257.53
-0.18
(-0.07%)
After-Hours: 20:00
Cencora EPS Diluted (Quarterly) : 8.401 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cardinal Health, Inc. | 1.691 |
| McKesson Corp. | 13.71 |
| Henry Schein, Inc. | 0.9219 |
| Accendra Health, Inc. | -0.0846 |
| PD-Rx Pharmaceuticals, Inc. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.630B |
| Revenue (Quarterly) | 78.36B |
| Total Expenses (Quarterly) | 76.71B |
| Enterprise Value | 60.48B |
| Gross Profit Margin (Quarterly) | 4.24% |
| Profit Margin (Quarterly) | 2.08% |
| Earnings Yield | 5.06% |
| Operating Earnings Yield | 8.34% |
| Normalized Earnings Yield | 7.122 |